Patents by Inventor Manoj Atmaramji UPADHYA
Manoj Atmaramji UPADHYA has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20240066014Abstract: The invention relates to a method of treating or preventing Parkinson's disease in a subject comprising administering a compound of Formula I wherein, R1 is —NHC(O) C3-6 cycloalkyl and R2 is hydrogen; or R1 and R2 along with the carbon atoms to which they are attached form a six membered aromatic ring, wherein the ring is substituted with one or more groups selected from hydrogen, halogen and C1-6 alkyl; R3 and R4 are independently selected from group comprising hydrogen, halogen, C1-3 alkyl, OC1-3 alkyl, NO2, SC1-3 alkyl, C1-3 haloalkyl, OC1-3 haloalkyl, and SC1-3 haloalkyl; or a pharmaceutically acceptable salt thereof.Type: ApplicationFiled: October 11, 2023Publication date: February 29, 2024Applicant: SUN PHARMA ADVANCED RESEARCH COMPANY LTD.Inventors: Nitin Krishnaji DAMLE, Sanjay Nandlalji MANDHANE, Manoj Atmaramji UPADHYA, Sameer Vishwanath MEHETRE, Gajanan Uttamrao CHIDREWAR, Prabal SENGUPTA, Trinadha Rao CHITTURI
-
Patent number: 11813252Abstract: The invention relates to a method of treating or preventing Parkinson's disease in a subject comprising administering a compound of Formula I wherein, R1 is —NHC(O) C3-6 cycloalkyl and R2 is hydrogen; or R1 and R2 along with the carbon atoms to which they are attached form a six membered aromatic ring, wherein the ring is substituted with one or more groups selected from hydrogen, halogen and C1-6 alkyl; R3 and R4 are independently selected from group comprising hydrogen, halogen, C1-3 alkyl, OC1-3 alkyl, NO2, SC1-3 alkyl, C1-3 haloalkyl, OC1-3 haloalkyl, and SC1-3 haloalkyl; or a pharmaceutically acceptable salt thereof.Type: GrantFiled: May 18, 2022Date of Patent: November 14, 2023Assignee: SUN PHARMA ADVANCED RESEARCH COMPANY LTD.Inventors: Nitin Krishnaji Damle, Sanjay Nandlalji Mandhane, Manoj Atmaramji Upadhya, Sameer Vishwanath Mehetre, Gajanan Uttamrao Chidrewar, Prabal Sengupta, Trinadha Rao Chitturi
-
Patent number: 11583522Abstract: The invention relates to a method of treating or preventing Parkinson's disease in a subject comprising administering a compound of Formula I wherein, R1 is —NHC(O) C3-6 cycloalkyl and R2 is hydrogen; or R1 and R2 along with the carbon atoms to which they are attached form a six membered aromatic ring, wherein the ring is substituted with one or more groups selected from hydrogen, halogen and C1-6 alkyl; R3 and R4 are independently selected from group comprising hydrogen, halogen, C1-3 alkyl, OC1-3 alkyl, NO2, SC1-3 alkyl, C1-3 haloalkyl, OC1-3 haloalkyl, and SC1-3 haloalkyl; or a pharmaceutically acceptable salt thereof.Type: GrantFiled: October 1, 2020Date of Patent: February 21, 2023Assignee: SUN PHARMA ADVANCED RESEARCH COMPANY LTD.Inventors: Nitin Krishnaji Damle, Sanjay Nandlalji Mandhane, Manoj Atmaramji Upadhya, Sameer Vishwanath Mehetre, Gajanan Uttamrao Chidrewar, Prabal Sengupta, Trinadha Rao Chitturi
-
Publication number: 20220273632Abstract: The invention relates to a method of treating or preventing Parkinson's disease in a subject comprising administering a compound of Formula I wherein, R1 is —NHC(O) C3-6 cycloalkyl and R2 is hydrogen; or R1 and R2 along with the carbon atoms to which they are attached form a six membered aromatic ring, wherein the ring is substituted with one or more groups selected from hydrogen, halogen and C1-6 alkyl; R3 and R4 are independently selected from group comprising hydrogen, halogen, C1-3 alkyl, OC1-3 alkyl, NO2, SC1-3 alkyl, C1-3 haloalkyl, OC1-3 haloalkyl, and SC1-3 haloalkyl; or a pharmaceutically acceptable salt thereof.Type: ApplicationFiled: May 18, 2022Publication date: September 1, 2022Applicant: SUN PHARMA ADVANCED RESEARCH COMPANY LTD.Inventors: Nitin Krishnaji DAMLE, Sanjay Nandlalji MANDHANE, Manoj Atmaramji UPADHYA, Sameer Vishwanath MEHETRE, Gajanan Uttamrao CHIDREWAR, Prabal SENGUPTA, Trinadha Rao CHITTURI
-
Publication number: 20210015805Abstract: The invention relates to a method of treating or preventing Parkinson's disease in a subject comprising administering a compound of Formula I wherein, R1 is —NHC(O) C3-6 cycloalkyl and R2 is hydrogen; or R1 and R2 along with the carbon atoms to which they are attached form a six membered aromatic ring, wherein the ring is substituted with one or more groups selected from hydrogen, halogen and C1-6 alkyl; R3 and R4 are independently selected from group comprising hydrogen, halogen, C1-3 alkyl, OC1-3 alkyl, NO2, SC1-3 alkyl, C1-3 haloalkyl, OC1-3 haloalkyl, and SC1-3 haloalkyl; or a pharmaceutically acceptable salt thereof.Type: ApplicationFiled: October 1, 2020Publication date: January 21, 2021Applicant: SUN PHARMA ADVANCED RESEARCH COMPANY LTD.Inventors: Nitin Krishnaji DAMLE, Sanjay Nandlalji MANDHANE, Manoj Atmaramji UPADHYA, Sameer Vishwanath MEHETRE, Gajanan Uttamrao CHIDREWAR, Prabal SENGUPTA, Trinadha Rao CHITTURI
-
Patent number: 10849887Abstract: The invention relates to a method of treating or preventing Parkinson's disease in a subject comprising administering a compound of Formula I wherein, R1 is —NHC(O) C3-6 cycloalkyl and R2 is hydrogen; or R1 and R2 along with the carbon atoms to which they are attached form a six membered aromatic ring, wherein the ring is substituted with one or more groups selected from hydrogen, halogen and C1-6 alkyl; R3 and R4 are independently selected from group comprising hydrogen, halogen, C1-3 alkyl, OC1-3 alkyl, NO2, SC1-3, alkyl, C1-3, haloalkyl, OC1-3 haloalkyl, and SC1-3 haloalkyl; or a pharmaceutically acceptable salt thereof.Type: GrantFiled: June 2, 2017Date of Patent: December 1, 2020Assignee: SUN PHARMA ADVANCED RESEARCH COMPANY LTD.Inventors: Nitin Krishnaji Damle, Sanjay Nandlalji Mandhane, Manoj Atmaramji Upadhya, Sameer Vishwanath Mehetre, Gajanan Uttamrao Chidrewar, Prabal Sengupta, Trinadha Rao Chitturi
-
Publication number: 20190275017Abstract: The invention relates to a method of treating or preventing Parkinson's disease in a subject comprising administering a compound of Formula I wherein, R1 is —NHC(O) C3-6 cycloalkyl and R2 is hydrogen; or R1 and R2 along with the carbon atoms to which they are attached form a six membered aromatic ring, wherein the ring is substituted with one or more groups selected from hydrogen, halogen and C1-6 alkyl; R3 and R4 are independently selected from group comprising hydrogen, halogen, C1-3 alkyl, OC1-3 alkyl, NO2, SC1-3, alkyl, C1-3, haloalkyl, OC1-3 haloalkyl, and SC1-3 haloalkyl; or a pharmaceutically acceptable salt thereof.Type: ApplicationFiled: June 2, 2017Publication date: September 12, 2019Applicant: SUN PHARMA ADVANCED RESEARCH COMPANY LTD.Inventors: Nitin Krishnaji DAMLE, Sanjay Nandlalji MANDHANE, Manoj Atmaramji UPADHYA, Sameer Vishwanath MEHETRE, Gajanan Uttamrao CHIDREWAR, Prabal SENGUPTA, Trinadha Rao CHITTURI